Comparison of prognostic impact between positive intraoperative peritoneal and lavage cytologies in colorectal cancer

Background The prognostic value of positive intraoperative peritoneal cytology and lavage cytology, including the differences in their prognostic impact, in colorectal cancer is controversial. We aimed to investigate the prognostic values of positive peritoneal cytology and lavage cytology findings...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of clinical oncology 2021-07, Vol.26 (7), p.1272-1284
Hauptverfasser: Sato, Kentaro, Imaizumi, Ken, Kasajima, Hiroyuki, Kurushima, Michihiro, Umehara, Minoru, Tsuruga, Yosuke, Yamana, Daisuke, Obuchi, Keisuke, Sato, Aya, Nakanishi, Kazuaki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1284
container_issue 7
container_start_page 1272
container_title International journal of clinical oncology
container_volume 26
creator Sato, Kentaro
Imaizumi, Ken
Kasajima, Hiroyuki
Kurushima, Michihiro
Umehara, Minoru
Tsuruga, Yosuke
Yamana, Daisuke
Obuchi, Keisuke
Sato, Aya
Nakanishi, Kazuaki
description Background The prognostic value of positive intraoperative peritoneal cytology and lavage cytology, including the differences in their prognostic impact, in colorectal cancer is controversial. We aimed to investigate the prognostic values of positive peritoneal cytology and lavage cytology findings for colorectal cancer and compare their prognostic impact. Methods We retrospectively evaluated 592 clinical stage II–IV colorectal cancer patients who underwent peritoneal cytology ( n  = 225) or lavage cytology ( n  = 367) between November 1993 and December 2018. The prognostic factors for cancer-specific survival were identified, and the differences in cancer-specific survival were examined between the patients. Results The cytology-positive rate was 10.8% (64/592), 17.8% (40/225), and 6.5% (24/367) in the overall, peritoneal cytology, and lavage cytology groups, respectively. Both positive peritoneal cytology (hazard ratio: 2.196) and lavage cytology (hazard ratio: 2.319) were independent prognostic factors. The peritoneal cytology-positive group showed significantly poorer cancer-specific survival than the cytology-negative group (5-year: 3.5% vs. 59.5%; 10-year: 3.5% vs. 46.1%, p  
doi_str_mv 10.1007/s10147-021-01918-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2511896176</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2542531942</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-fd1b6cfee063d5deb1331caca83d0c30fd14fa2281b7aa3b94b55c60c32ff8073</originalsourceid><addsrcrecordid>eNp9kU9vFSEUxYnR2D_6BVwYEjduRrnADDNL81LbJk3c6JowzJ0XmnkwAlPTb--1r9bERVdcOL97LnAYewfiEwhhPhcQoE0jJDQCBuib_gU7Ba1MY4yRL6lWGpqhk-0JOyvlVggwXStfsxOleq0B4JRtu3RYXQ4lRZ5mvua0j6nU4Hmgc1_5iPUXYuRrKqGGO-Qh1uzSitk9bKkINUV0C3dx4ou7c3vk_r6mJe0DFuK5pzqjr8R4Fz3mN-zV7JaCbx_Xc_bj68X33VVz8-3yevflpvFqGGozTzB2fkYUnZraCUdQCrzzrleT8EqQrmcnZQ-jcU6Ngx7b1nckyXnuhVHn7OPRl971c8NS7SEUj8viIqatWNkC9ENH30Loh__Q27TlSLcjSstWwaAlUfJI-ZxKyTjbNYeDy_cWhP0Tij2GYikU-xCK7anp_aP1Nh5wemr5mwIB6ggUkuIe87_Zz9j-Bkkjmmo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2542531942</pqid></control><display><type>article</type><title>Comparison of prognostic impact between positive intraoperative peritoneal and lavage cytologies in colorectal cancer</title><source>Springer Nature - Complete Springer Journals</source><creator>Sato, Kentaro ; Imaizumi, Ken ; Kasajima, Hiroyuki ; Kurushima, Michihiro ; Umehara, Minoru ; Tsuruga, Yosuke ; Yamana, Daisuke ; Obuchi, Keisuke ; Sato, Aya ; Nakanishi, Kazuaki</creator><creatorcontrib>Sato, Kentaro ; Imaizumi, Ken ; Kasajima, Hiroyuki ; Kurushima, Michihiro ; Umehara, Minoru ; Tsuruga, Yosuke ; Yamana, Daisuke ; Obuchi, Keisuke ; Sato, Aya ; Nakanishi, Kazuaki</creatorcontrib><description>Background The prognostic value of positive intraoperative peritoneal cytology and lavage cytology, including the differences in their prognostic impact, in colorectal cancer is controversial. We aimed to investigate the prognostic values of positive peritoneal cytology and lavage cytology findings for colorectal cancer and compare their prognostic impact. Methods We retrospectively evaluated 592 clinical stage II–IV colorectal cancer patients who underwent peritoneal cytology ( n  = 225) or lavage cytology ( n  = 367) between November 1993 and December 2018. The prognostic factors for cancer-specific survival were identified, and the differences in cancer-specific survival were examined between the patients. Results The cytology-positive rate was 10.8% (64/592), 17.8% (40/225), and 6.5% (24/367) in the overall, peritoneal cytology, and lavage cytology groups, respectively. Both positive peritoneal cytology (hazard ratio: 2.196) and lavage cytology (hazard ratio: 2.319) were independent prognostic factors. The peritoneal cytology-positive group showed significantly poorer cancer-specific survival than the cytology-negative group (5-year: 3.5% vs. 59.5%; 10-year: 3.5% vs. 46.1%, p  &lt; 0.001). Similar results were obtained for lavage cytology (5-year: 14.1% vs. 73.9%; 10-year: 4.7% vs. 63.5%, p  &lt; 0.001). The cancer-specific survival was not significantly different between the peritoneal cytology-positive and lavage cytology-positive groups ( p  = 0.058). Both positive peritoneal and lavage cytology were associated with poorer cancer-specific survival across all colorectal cancer stages. Conclusions Positive peritoneal and lavage cytology are associated with worse cancer-specific survival in colorectal cancer. The prognostic impact was comparable between positive lavage and peritoneal cytology. Thus, cytology should be a standard assessment modality for colorectal cancer.</description><identifier>ISSN: 1341-9625</identifier><identifier>EISSN: 1437-7772</identifier><identifier>DOI: 10.1007/s10147-021-01918-8</identifier><identifier>PMID: 33844111</identifier><language>eng</language><publisher>Singapore: Springer Singapore</publisher><subject>Cancer ; Cancer Research ; Cellular biology ; Colorectal cancer ; Colorectal carcinoma ; Cytology ; Lavage ; Medical prognosis ; Medicine ; Medicine &amp; Public Health ; Oncology ; Original Article ; Peritoneum ; Surgical Oncology ; Survival</subject><ispartof>International journal of clinical oncology, 2021-07, Vol.26 (7), p.1272-1284</ispartof><rights>Japan Society of Clinical Oncology 2021</rights><rights>Japan Society of Clinical Oncology 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-fd1b6cfee063d5deb1331caca83d0c30fd14fa2281b7aa3b94b55c60c32ff8073</citedby><cites>FETCH-LOGICAL-c399t-fd1b6cfee063d5deb1331caca83d0c30fd14fa2281b7aa3b94b55c60c32ff8073</cites><orcidid>0000-0002-7751-6270</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10147-021-01918-8$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10147-021-01918-8$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33844111$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sato, Kentaro</creatorcontrib><creatorcontrib>Imaizumi, Ken</creatorcontrib><creatorcontrib>Kasajima, Hiroyuki</creatorcontrib><creatorcontrib>Kurushima, Michihiro</creatorcontrib><creatorcontrib>Umehara, Minoru</creatorcontrib><creatorcontrib>Tsuruga, Yosuke</creatorcontrib><creatorcontrib>Yamana, Daisuke</creatorcontrib><creatorcontrib>Obuchi, Keisuke</creatorcontrib><creatorcontrib>Sato, Aya</creatorcontrib><creatorcontrib>Nakanishi, Kazuaki</creatorcontrib><title>Comparison of prognostic impact between positive intraoperative peritoneal and lavage cytologies in colorectal cancer</title><title>International journal of clinical oncology</title><addtitle>Int J Clin Oncol</addtitle><addtitle>Int J Clin Oncol</addtitle><description>Background The prognostic value of positive intraoperative peritoneal cytology and lavage cytology, including the differences in their prognostic impact, in colorectal cancer is controversial. We aimed to investigate the prognostic values of positive peritoneal cytology and lavage cytology findings for colorectal cancer and compare their prognostic impact. Methods We retrospectively evaluated 592 clinical stage II–IV colorectal cancer patients who underwent peritoneal cytology ( n  = 225) or lavage cytology ( n  = 367) between November 1993 and December 2018. The prognostic factors for cancer-specific survival were identified, and the differences in cancer-specific survival were examined between the patients. Results The cytology-positive rate was 10.8% (64/592), 17.8% (40/225), and 6.5% (24/367) in the overall, peritoneal cytology, and lavage cytology groups, respectively. Both positive peritoneal cytology (hazard ratio: 2.196) and lavage cytology (hazard ratio: 2.319) were independent prognostic factors. The peritoneal cytology-positive group showed significantly poorer cancer-specific survival than the cytology-negative group (5-year: 3.5% vs. 59.5%; 10-year: 3.5% vs. 46.1%, p  &lt; 0.001). Similar results were obtained for lavage cytology (5-year: 14.1% vs. 73.9%; 10-year: 4.7% vs. 63.5%, p  &lt; 0.001). The cancer-specific survival was not significantly different between the peritoneal cytology-positive and lavage cytology-positive groups ( p  = 0.058). Both positive peritoneal and lavage cytology were associated with poorer cancer-specific survival across all colorectal cancer stages. Conclusions Positive peritoneal and lavage cytology are associated with worse cancer-specific survival in colorectal cancer. The prognostic impact was comparable between positive lavage and peritoneal cytology. Thus, cytology should be a standard assessment modality for colorectal cancer.</description><subject>Cancer</subject><subject>Cancer Research</subject><subject>Cellular biology</subject><subject>Colorectal cancer</subject><subject>Colorectal carcinoma</subject><subject>Cytology</subject><subject>Lavage</subject><subject>Medical prognosis</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Peritoneum</subject><subject>Surgical Oncology</subject><subject>Survival</subject><issn>1341-9625</issn><issn>1437-7772</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kU9vFSEUxYnR2D_6BVwYEjduRrnADDNL81LbJk3c6JowzJ0XmnkwAlPTb--1r9bERVdcOL97LnAYewfiEwhhPhcQoE0jJDQCBuib_gU7Ba1MY4yRL6lWGpqhk-0JOyvlVggwXStfsxOleq0B4JRtu3RYXQ4lRZ5mvua0j6nU4Hmgc1_5iPUXYuRrKqGGO-Qh1uzSitk9bKkINUV0C3dx4ou7c3vk_r6mJe0DFuK5pzqjr8R4Fz3mN-zV7JaCbx_Xc_bj68X33VVz8-3yevflpvFqGGozTzB2fkYUnZraCUdQCrzzrleT8EqQrmcnZQ-jcU6Ngx7b1nckyXnuhVHn7OPRl971c8NS7SEUj8viIqatWNkC9ENH30Loh__Q27TlSLcjSstWwaAlUfJI-ZxKyTjbNYeDy_cWhP0Tij2GYikU-xCK7anp_aP1Nh5wemr5mwIB6ggUkuIe87_Zz9j-Bkkjmmo</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Sato, Kentaro</creator><creator>Imaizumi, Ken</creator><creator>Kasajima, Hiroyuki</creator><creator>Kurushima, Michihiro</creator><creator>Umehara, Minoru</creator><creator>Tsuruga, Yosuke</creator><creator>Yamana, Daisuke</creator><creator>Obuchi, Keisuke</creator><creator>Sato, Aya</creator><creator>Nakanishi, Kazuaki</creator><general>Springer Singapore</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7751-6270</orcidid></search><sort><creationdate>20210701</creationdate><title>Comparison of prognostic impact between positive intraoperative peritoneal and lavage cytologies in colorectal cancer</title><author>Sato, Kentaro ; Imaizumi, Ken ; Kasajima, Hiroyuki ; Kurushima, Michihiro ; Umehara, Minoru ; Tsuruga, Yosuke ; Yamana, Daisuke ; Obuchi, Keisuke ; Sato, Aya ; Nakanishi, Kazuaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-fd1b6cfee063d5deb1331caca83d0c30fd14fa2281b7aa3b94b55c60c32ff8073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cancer</topic><topic>Cancer Research</topic><topic>Cellular biology</topic><topic>Colorectal cancer</topic><topic>Colorectal carcinoma</topic><topic>Cytology</topic><topic>Lavage</topic><topic>Medical prognosis</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Peritoneum</topic><topic>Surgical Oncology</topic><topic>Survival</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sato, Kentaro</creatorcontrib><creatorcontrib>Imaizumi, Ken</creatorcontrib><creatorcontrib>Kasajima, Hiroyuki</creatorcontrib><creatorcontrib>Kurushima, Michihiro</creatorcontrib><creatorcontrib>Umehara, Minoru</creatorcontrib><creatorcontrib>Tsuruga, Yosuke</creatorcontrib><creatorcontrib>Yamana, Daisuke</creatorcontrib><creatorcontrib>Obuchi, Keisuke</creatorcontrib><creatorcontrib>Sato, Aya</creatorcontrib><creatorcontrib>Nakanishi, Kazuaki</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sato, Kentaro</au><au>Imaizumi, Ken</au><au>Kasajima, Hiroyuki</au><au>Kurushima, Michihiro</au><au>Umehara, Minoru</au><au>Tsuruga, Yosuke</au><au>Yamana, Daisuke</au><au>Obuchi, Keisuke</au><au>Sato, Aya</au><au>Nakanishi, Kazuaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of prognostic impact between positive intraoperative peritoneal and lavage cytologies in colorectal cancer</atitle><jtitle>International journal of clinical oncology</jtitle><stitle>Int J Clin Oncol</stitle><addtitle>Int J Clin Oncol</addtitle><date>2021-07-01</date><risdate>2021</risdate><volume>26</volume><issue>7</issue><spage>1272</spage><epage>1284</epage><pages>1272-1284</pages><issn>1341-9625</issn><eissn>1437-7772</eissn><abstract>Background The prognostic value of positive intraoperative peritoneal cytology and lavage cytology, including the differences in their prognostic impact, in colorectal cancer is controversial. We aimed to investigate the prognostic values of positive peritoneal cytology and lavage cytology findings for colorectal cancer and compare their prognostic impact. Methods We retrospectively evaluated 592 clinical stage II–IV colorectal cancer patients who underwent peritoneal cytology ( n  = 225) or lavage cytology ( n  = 367) between November 1993 and December 2018. The prognostic factors for cancer-specific survival were identified, and the differences in cancer-specific survival were examined between the patients. Results The cytology-positive rate was 10.8% (64/592), 17.8% (40/225), and 6.5% (24/367) in the overall, peritoneal cytology, and lavage cytology groups, respectively. Both positive peritoneal cytology (hazard ratio: 2.196) and lavage cytology (hazard ratio: 2.319) were independent prognostic factors. The peritoneal cytology-positive group showed significantly poorer cancer-specific survival than the cytology-negative group (5-year: 3.5% vs. 59.5%; 10-year: 3.5% vs. 46.1%, p  &lt; 0.001). Similar results were obtained for lavage cytology (5-year: 14.1% vs. 73.9%; 10-year: 4.7% vs. 63.5%, p  &lt; 0.001). The cancer-specific survival was not significantly different between the peritoneal cytology-positive and lavage cytology-positive groups ( p  = 0.058). Both positive peritoneal and lavage cytology were associated with poorer cancer-specific survival across all colorectal cancer stages. Conclusions Positive peritoneal and lavage cytology are associated with worse cancer-specific survival in colorectal cancer. The prognostic impact was comparable between positive lavage and peritoneal cytology. Thus, cytology should be a standard assessment modality for colorectal cancer.</abstract><cop>Singapore</cop><pub>Springer Singapore</pub><pmid>33844111</pmid><doi>10.1007/s10147-021-01918-8</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-7751-6270</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1341-9625
ispartof International journal of clinical oncology, 2021-07, Vol.26 (7), p.1272-1284
issn 1341-9625
1437-7772
language eng
recordid cdi_proquest_miscellaneous_2511896176
source Springer Nature - Complete Springer Journals
subjects Cancer
Cancer Research
Cellular biology
Colorectal cancer
Colorectal carcinoma
Cytology
Lavage
Medical prognosis
Medicine
Medicine & Public Health
Oncology
Original Article
Peritoneum
Surgical Oncology
Survival
title Comparison of prognostic impact between positive intraoperative peritoneal and lavage cytologies in colorectal cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T20%3A14%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20prognostic%20impact%20between%20positive%20intraoperative%20peritoneal%20and%20lavage%20cytologies%20in%20colorectal%20cancer&rft.jtitle=International%20journal%20of%20clinical%20oncology&rft.au=Sato,%20Kentaro&rft.date=2021-07-01&rft.volume=26&rft.issue=7&rft.spage=1272&rft.epage=1284&rft.pages=1272-1284&rft.issn=1341-9625&rft.eissn=1437-7772&rft_id=info:doi/10.1007/s10147-021-01918-8&rft_dat=%3Cproquest_cross%3E2542531942%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2542531942&rft_id=info:pmid/33844111&rfr_iscdi=true